Corbus Pharmaceuticals Holdings, Inc.
NASDAQ:CRBP · NASDAQ Capital Market
+$0.14 today
Vol 0.30M · Avg 0.42M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+4.69%
Period High
$19.36
Period Low
$6.90
Latest
$8.26
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Forte Biosciences, Inc.
NASDAQ:FBRX
$248.62M
Alector, Inc.
NASDAQ:ALEC
$181.90M
Innate Pharma S.A.
NASDAQ:IPHA
$170.34M
Molecular Partners AG
NASDAQ:MOLN
$147.61M
PepGen Inc.
NASDAQ:PEPG
$123.81M
Milestone Pharmaceuticals Inc.
NASDAQ:MIST
$112.51M
Cardiff Oncology, Inc.
NASDAQ:CRDF
$82.39M
Elicio Therapeutics, Inc.
NASDAQ:ELTX
$73.29M
Rani Therapeutics Holdings, Inc.
NASDAQ:RANI
$50.59M
Applied Therapeutics, Inc.
APLT
$14.86M
What is the latest CRBP filing?
The latest filing shown is S-8 dated Jun 17, 2026.
How many recent filings does CRBP have?
Intrinsic Alpha currently shows 20 recent filings for CRBP.
Explore More
Continue the stock analysis
Jump to another research area for this company.